重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 10 月 23 日 证券代码：688185 证券简称：康希诺 公告编号：2025-029 康希诺生物股份公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 （二） 股东大会召开的地点：天津市河东区卫国道 126 号天津东凯悦酒店二层 悦宾厅 1 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 230 | | --- | --- | | 股股东人数 其中：A | 229 | | 股股东人数 H | 1 | | 2、出席会议的股东所持有的表决权数量 | 94,408,299 | | 其中：A 股股东所持有表决权数量 | 46,850,612 | | 股股东所持有表决权数量 H | 47,557,687 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比例 | 38.22 | | ...

中国北京市朝阳区建国路 77 号华贸中心 3 号写字楼 34 层 邮政编码 100025 电话: （8610）58091000 传真: （8610）58091100 北京市竞天公诚律师事务所 关于康希诺生物股份公司 致：康希诺生物股份公司 根据《中华人民共和国证券法》《中华人民共和国公司法》以及中国证券监 督管理委员会颁布的《上市公司股东会规则》（以下简称"《股东会规则》"） 的规定，北京市竞天公诚律师事务所（以下简称"本所"）指派律师现场出席了 康希诺生物股份公司（以下简称"公司"）2025 年第一次临时股东大会（以下 简称"本次股东大会"），并就本次股东大会的相关事宜出具本法律意见书。 本所及经办律师依据《中华人民共和国证券法》《律师事务所从事证券法律 业务管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定及本法 律意见书出具日以前已经发生或者存在的事实，严格履行了法定职责，遵循了勤 勉尽责和诚实信用原则，进行了充分的核查验证，保证本法律意见书所认定的事 实真实、准确、完整，所发表的意见合法、准确，不存在虚假记载、误导性陈述 或者重大遗漏，并承担相应法律责任。 本所同意，公司可以将本法律意见书作 ...

Core Viewpoint - The company is on track to complete the first patient dosing of its mRNA tumor vaccine within this year, focusing on glioblastoma and rhabdomyosarcoma indications [2] Company Progress - The company confirmed that the development of the mRNA vaccine is proceeding as planned and that the progress is in line with expectations [2] - Investors are encouraged to follow the company's official updates for further information on the vaccine's development [2]

Group 1 - The core viewpoint of the news is that CanSino Biologics has experienced fluctuations in its stock price and trading volume, with a current market capitalization of 18.353 billion yuan and a year-to-date stock price increase of 21.49% [1] - As of October 20, CanSino's stock price rose by 2.02% to 74.17 yuan per share, with a trading volume of 43.2395 million yuan and a turnover rate of 0.51% [1] - The company has seen a net inflow of main funds amounting to 1.2986 million yuan, with significant buying and selling activities recorded [1] Group 2 - For the first half of 2025, CanSino reported an operating income of 382 million yuan, representing a year-on-year growth of 26% [2] - The net profit attributable to the parent company for the same period was -13.4854 million yuan, showing a year-on-year increase of 94.02% in losses [2] - The number of shareholders as of June 30 was 17,500, a decrease of 1.92% from the previous period [2] Group 3 - Since its A-share listing, CanSino has distributed a total of 198 million yuan in dividends, with no dividends paid in the last three years [3]

康希诺生物股份公司 2025 年第一次临时股东大会 证券代码：688185 证券简称：康希诺 康希诺生物股份公司 康希诺生物股份公司 2025 年第一次临时股东大会会议须知 2025 年 10 月 康希诺生物股份公司 2025 年第一次临时股东大会 目录 | 2025 年第一次临时股东大会会议议程 4 | | | | | --- | --- | --- | --- | | 2025 年第一次临时股东大会会议议案 6 | | | | | 议案一：关于公司《2025 年 股限制性股票激励计划（草案）》及其摘要的议案 6 | | A | | | 议案二：关于公司《2025 年 股限制性股票激励计划实施考核管理办法》的议案 7 | | A | | | 议案三：关于提请股东大会授权董事会办理 2025 年 A | | | 股限制性股票激励计划相关事宜 | | 的议案 8 | | | | | 年 议案四：关于公司《2025 股购股权计划》的议案 11 | | H | | | 议案五：关于提请股东大会授权董事会办理 年 2025 H | | | 股购股权计划相关事宜的议案12 | | 议案六：关于向 博士授予 H 股购股权 ...

证券代码：688185 证券简称：康希诺 公告编号：2025-028 康希诺生物股份公司 监事会关于公司 2025 年 A 股限制性股票激励计划 首次授予激励对象名单的公示情况说明及核查意见 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 康希诺生物股份公司（以下简称"公司"）于 2025 年 9 月 26 日召开第三届 董事会第二次临时会议、第三届监事会第九次会议，审议通过了《关于公司<2025 年 A 股限制性股票激励计划（草案）>及其摘要的议案》等相关议案。根据《上 市公司股权激励管理办法》（以下简称"《管理办法》"）等有关法律、法规及 规范性文件的相关规定，公司对 2025 年 A 股限制性股票激励计划（以下简称"本 激励计划"）拟首次授予的激励对象的姓名和职务在公司内部进行了公示，公司 监事会结合公示情况对激励对象名单进行了核查，相关公示情况及核查意见如下： 一、公示情况 1、公司于 2025 年 9 月 27 日在上海证券交易所网站（www.sse.com.cn）披 露了《康希诺生物股份公司 2025 年 A ...

Core Viewpoint - The A-share market experienced a decline today, with the Shanghai Composite Index dropping by 1.39% and trading volume decreasing by 4.76% compared to the previous trading day [1] Industry Performance Summary - **Coal**: Slight increase of 0.12% with a transaction amount of 165.48 billion yuan, led by Antai Group which rose by 10.00% [1] - **Banking**: Minor decrease of 0.04% with a transaction amount of 302.99 billion yuan, led by Shanghai Bank which fell by 0.83% [1] - **Steel**: Decrease of 0.09% with a transaction amount of 133.07 billion yuan, led by Wujin Stainless Steel which dropped by 7.73% [1] - **Transportation**: Decrease of 0.11% with a transaction amount of 258.60 billion yuan, led by Pulutong which fell by 3.36% [1] - **Textiles and Apparel**: Decrease of 0.25% with a transaction amount of 119.79 billion yuan, led by Yingfeng Shares which dropped by 9.99% [1] - **Oil and Petrochemicals**: Decrease of 0.29% with a transaction amount of 83.04 billion yuan, led by Compton which fell by 3.19% [1] - **Agriculture, Forestry, Animal Husbandry, and Fishery**: Decrease of 0.45% with a transaction amount of 139.82 billion yuan, led by Aonong Biological which dropped by 4.66% [1] - **Real Estate**: Decrease of 0.52% with a transaction amount of 213.60 billion yuan, led by Wolong New Energy which fell by 7.80% [1] - **Utilities**: Decrease of 0.52% with a transaction amount of 302.04 billion yuan, led by *ST Lingda which dropped by 13.20% [1] - **Construction and Decoration**: Decrease of 0.75% with a transaction amount of 278.81 billion yuan, led by Kexin Development which fell by 8.15% [1] - **Home Appliances**: Decrease of 0.79% with a transaction amount of 217.37 billion yuan, led by Greer which dropped by 6.72% [1] - **Food and Beverage**: Decrease of 0.86% with a transaction amount of 194.67 billion yuan, led by Huaiqi Mountain which fell by 6.44% [1] - **Environmental Protection**: Decrease of 0.92% with a transaction amount of 140.79 billion yuan, led by Science which dropped by 6.68% [1] - **Retail**: Decrease of 0.97% with a transaction amount of 173.43 billion yuan, led by Ruoyu Chen which fell by 9.98% [1] - **Social Services**: Decrease of 1.07% with a transaction amount of 89.87 billion yuan, led by Chuangye Heima which dropped by 5.28% [1] - **Light Industry Manufacturing**: Decrease of 1.12% with a transaction amount of 135.66 billion yuan, led by Songyang Resources which fell by 10.02% [1] - **Pharmaceuticals and Biology**: Decrease of 1.16% with a transaction amount of 845.22 billion yuan, led by Warner Pharmaceuticals which dropped by 7.67% [1] - **Basic Chemicals**: Decrease of 1.21% with a transaction amount of 618.91 billion yuan, led by Xinong Shares which fell by 8.88% [1] - **Non-ferrous Metals**: Decrease of 1.24% with a transaction amount of 1149.11 billion yuan, led by Galaxy Magnetics which dropped by 7.14% [1] - **Telecommunications**: Decrease of 1.28% with a transaction amount of 806.90 billion yuan, led by Shijia Photon which fell by 17.59% [1] - **Non-bank Financials**: Decrease of 1.39% with a transaction amount of 491.74 billion yuan, led by Hainan Huatie which dropped by 6.17% [1] - **Building Materials**: Decrease of 1.66% with a transaction amount of 94.02 billion yuan, led by Yaopi Glass which fell by 7.82% [1] - **Media**: Decrease of 1.68% with a transaction amount of 263.96 billion yuan, led by Vision China which dropped by 9.93% [1] - **Beauty and Personal Care**: Decrease of 1.76% with a transaction amount of 33.94 billion yuan, led by Baiya Shares which fell by 4.98% [1] - **Computers**: Decrease of 2.38% with a transaction amount of 1005.18 billion yuan, led by Kaipu Cloud which dropped by 11.94% [1] - **Comprehensive**: Decrease of 2.42% with a transaction amount of 27.84 billion yuan, led by Dongyangguang which fell by 4.70% [1] - **Defense and Military Industry**: Decrease of 2.55% with a transaction amount of 387.73 billion yuan, led by Hangyu Technology which dropped by 8.38% [1] - **Machinery and Equipment**: Decrease of 2.68% with a transaction amount of 940.87 billion yuan, led by Yingweike which fell by 10.00% [1] - **Automobiles**: Decrease of 2.69% with a transaction amount of 775.95 billion yuan, led by Tianpu Shares which dropped by 10.00% [1] - **Electronics**: Decrease of 3.19% with a transaction amount of 2631.19 billion yuan, led by Nanya New Materials which fell by 16.26% [1] - **Electric Power Equipment**: Decrease of 3.79% with a transaction amount of 1881.52 billion yuan, led by Shenghong Shares which dropped by 11.80% [1]

Core Viewpoint - The real estate sector experienced significant upward movement on October 16, with multiple companies showing strong performance, indicating a potential recovery or positive sentiment in the market [1] Company Performance - Shangshi Development achieved a two-day consecutive increase in stock price [1] - Shahe Co., Shenzhen Property A, and Hefei Urban Construction reached the daily limit increase [1] - Other companies such as Wolong New Energy, Dayue City, Phoenix Co., and Guangming Real Estate also saw price increases [1]

Core Insights - The real estate sector has experienced significant upward movement, with multiple companies showing strong performance in the market [1] Company Performance - Shanghai Shimao Development has achieved two consecutive trading limit increases [1] - Shahe Co., Shenzhen Properties A, and Hefei Urban Construction have reached their trading limits [1] - Other companies such as Wolong New Energy, Dayue City, Phoenix Holdings, and Bright Realty have also seen notable increases in their stock prices [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告的內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不就因本通告全部 或任何部分內容所產生或因依賴該等內容而引致的任何損失承擔任何責任。 CanSino Biologics Inc. 康希諾生物股份公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：6185） 董事會會議通告 康希諾生物股份公司 Xuefeng YU 董事長 香港，2025年10月15日 於本通告日期，本公司董事會包括執行董事Xuefeng YU博士、Shou Bai CHAO博 士 及王靖女士；非執行董事李志成先生；以及獨立非執行董事桂水發先生、劉建忠 先生及張耀樑先生。 康 希 諾 生 物 股 份 公 司（「本公司」）董 事（「董 事」）會（「董事會」）謹 此 宣 佈，董 事 會 會 議將於2025年10月27日（星 期 一）舉 行，藉 以（其 中 包 括）考 慮 及 批 准 本 公 司 及 其 附 屬公司截至2025年9月30日止九個月的第三季度業績及其發佈。 承董事會命 ...